GPC
53
-3
BIIB
46
-3
EXR
24
-4
ES
50
3
KLAC
70
5
ADSK
62
6
EL
61
3
AME
66
4
APA
48
-4
AA
76
3
PWR
53
2
TSCO
50
-3
FSLR
58
3
APH
49
4
NOC
48
-3
DGX
33
-3
CCL
65
3
HAS
66
2
MRK
60
2
PCAR
62
-2
GPC
53
-3
BIIB
46
-3
EXR
24
-4
ES
50
3
KLAC
70
5
ADSK
62
6
EL
61
3
AME
66
4
APA
48
-4
AA
76
3
PWR
53
2
TSCO
50
-3
FSLR
58
3
APH
49
4
NOC
48
-3
DGX
33
-3
CCL
65
3
HAS
66
2
MRK
60
2
PCAR
62
-2
Financhill
Back

Adaptive Hedged Multi-AssetETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell
28

AMAX
Adaptive Hedged Multi-AssetETF

Last Price:
$8.04
Seasonality Move:
0.15%
Sell
45

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$83.03
Seasonality Move:
-32.16%
Sell
28
Adaptive Hedged Multi-AssetETF (AMAX) is a Sell

Is Adaptive Hedged Multi-AssetETF a Buy, Sell or Hold?

  • The current Adaptive Hedged Multi-AssetETF [AMAX] share price is $7.96. The Score for AMAX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • AMAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Bright Minds Biosciences, Inc. (DRUG) is a Sell

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $78.88. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AMAX Stock Price Chart

What is Adaptive Hedged Multi-AssetETF's stock price today?

  • The Adaptive Hedged Multi-AssetETF share price today is $7.96
    The current trend is relatively stagnant and AMAX is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $78.88
    The current trend is moderately bullish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.

AMAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 41.41 Sell
Chaikin Money Flow: -21852 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.96 - 8.06) Sell
Bollinger Bands (100): (7.95 - 8.23) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.94 Buy
Relative Strength Index (14 RSI): 54.75 Buy
Chaikin Money Flow: -145421 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (60.39 - 83.51) Buy
Bollinger Bands (100): (41.65 - 69.37) Buy

AMAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.02 Sell
20-day SMA: 8.01 Sell
50-day SMA: 8.12 Sell
200-day SMA: 7.89 Buy
8-day EMA: 8 Sell
20-day EMA: 8.02 Sell
50-day EMA: 8.07 Sell
200-day EMA: 7.99 Sell

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.2 Sell
20-day SMA: 75.43 Buy
50-day SMA: 66.05 Buy
200-day SMA: 43.03 Buy
8-day EMA: 83.79 Sell
20-day EMA: 77.26 Buy
50-day EMA: 67.4 Buy
200-day EMA: 47.62 Buy

Adaptive Hedged Multi-AssetETF Earnings Growth & AMAX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.

Adaptive Hedged Multi-AssetETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):